During the past decade, Innovative Clinical Trials conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Innovative Clinical Trials" #1 sponsor was "AstraZeneca" with 1 trials, followed by "Forest Laboratories" with 1 trials sponsored, "Sanofi" with 1 trials sponsored, "Takeda" with 1 trials sponsored and "Winston Laboratories" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Innovative Clinical Trials" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Innovative Clinical Trials" are "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Chronic Constipation" (1 trials), "Gout" (1 trials), "Irritable Bowel Syndrome With Constipation" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Innovative Clinical Trials" in a lesser frequency.

Most popular intervention types in "Innovative Clinical Trials" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AC2993 10.0 mcg" (1 trials), "AC2993 2.5 mcg" (1 trials), "AC2993 5.0 mcg" (1 trials), "AC2993 7.5 mcg" (1 trials) and "Civamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Innovative Clinical Trials" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Innovative Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Innovative Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Innovative Clinical Trials, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".